Literature DB >> 17891663

Temperament and character dimensions in opiate addicts: comparing subjects who completed inpatient treatment in therapeutic communities vs. incompleters.

R Zoccali1, M R A Muscatello, A Bruno, F Bilardi, C De Stefano, E Felletti, S Isgrò, V Micalizzi, U Micò, A Romeo, M Meduri.   

Abstract

The aim of this study was to compare temperamental profiles of patients who completed inpatient treatment of drug dependence with those who failed to complete the program. One hundred forty four opiate addicts, all resident in therapeutic communities and screened to exclude Axis I disorders, were assessed using the Temperament and Character Inventory (TCI). After one year, the TCI scores were compared between those who were still resident and those who had dropped out. Significant differences between groups were found in Reward Dependence, Persistence, Cooperativeness, Self-Transcendence. Temperament and character features may have an influence on motivation and on the adherence to treatment and community rules, as they modulate the maintenance of ongoing behaviors and the sensitivity to social rewards. The findings suggest that personality assessment with TCI in opiate addicts may be helpful in screening procedures to increase the efficiency of treatment and rehabilitative strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17891663     DOI: 10.1080/00952990701522625

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  2 in total

1.  The impact of temperament and character inventory personality traits on long-term outcome of Roux-en-Y gastric bypass.

Authors:  Pedro Caldana Gordon; José Afonso Sallet; Paulo Clemente Sallet
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

2.  Personality Profile and Clinical Correlates of Patients With Substance Use Disorder With and Without Comorbid Depression Under Treatment.

Authors:  Julia Elena Marquez-Arrico; Laura Río-Martínez; José Francisco Navarro; Gemma Prat; Ana Adan
Journal:  Front Psychiatry       Date:  2019-01-11       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.